A Gregor

Author PubWeight™ 78.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999 4.81
2 Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2000 2.73
3 Management of lung cancer in South East Scotland. Thorax 1996 1.75
4 Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) 2005 1.61
5 Small-cell lung cancer after retinoblastoma. Lancet 1989 1.48
6 Long-term survival in patients with non-small cell lung cancer treated with palliative radiotherapy. Clin Oncol (R Coll Radiol) 2001 1.43
7 Dynamics of reactive oxygen intermediate production in human glioma: n-6 essential fatty acid effects. Eur J Clin Invest 1999 1.42
8 An audit of 3D treatment planning facilities and practice in the UK. Clin Oncol (R Coll Radiol) 1998 1.39
9 Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol 1997 1.35
10 Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol 1998 1.34
11 The impact of chemotherapy on small cell carcinoma of the bronchus. Q J Med 1986 1.26
12 Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 2000 1.17
13 A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. Cancer 2000 1.16
14 Imaging features of leptomeningeal metastases. Clin Radiol 1999 1.15
15 Radiographic progression of asbestosis: preliminary report. Ann N Y Acad Sci 1979 1.14
16 Colloid cyst of the third ventricle. A comparative immunohistochemical study of neuraxis cysts and choroid plexus epithelium. J Neurosurg 1993 1.12
17 Induction treatment before surgery for non-small cell lung cancer. Lung Cancer 2003 1.12
18 Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 1984 1.08
19 Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pharmacol 1984 1.07
20 The radiosensitivity of human neuroblastoma cells estimated from regrowth curves of multicellular tumour spheroids. Br J Radiol 1985 1.03
21 Early age of onset in fatal familial insomnia. Two novel cases and review of the literature. J Neurol 2004 1.02
22 Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. J Neurooncol 2003 1.00
23 Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study. Radiother Oncol 1998 0.98
24 Angiogenic histogenesis of stromal cells in hemangioblastoma: ultrastructural and immunohistochemical study. Ultrastruct Pathol 1999 0.97
25 A tumour spheroid model for antibody-targeted therapy of micrometastases. Br J Cancer 1988 0.95
26 Structures of fucose-containing glycolipids with H and B blood-group activity and of sialic acid and glucosamine-containing glycolipid of human-erythrocyte membrane. Eur J Biochem 1973 0.95
27 Significant change in tests of neurological impairment in patients with brain tumours. J Neurooncol 1998 0.91
28 Mutation hotspots in the human porphobilinogen deaminase gene: recurrent mutations G111R and R173Q occurring at CpG motifs. J Inherit Metab Dis 2004 0.90
29 Abnormalities in liver function and morphology and impaired aminopyrine metabolism in hereditary hepatic porphyrias. Gastroenterology 1983 0.89
30 The role of histocompatibility (HLA) antigens in asbestosis. Br J Dis Chest 1979 0.86
31 Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma. Prostaglandins Leukot Essent Fatty Acids 2002 0.86
32 A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party. Br J Cancer 1991 0.86
33 Radiation studies on multicellular tumour spheroids derived from human neuroblastoma: absence of sparing effect of dose fractionation. Eur J Cancer Clin Oncol 1986 0.85
34 Small cell carcinoma: combined approach to treatment. Thorax 1979 0.85
35 The costs of managing patients with malignant glioma at a neuro-oncology clinic. Br J Neurosurg 1998 0.85
36 Calcified cerebral metastasis from cervical carcinoma. Neuroradiology 1989 0.85
37 Referral pattern and management of patients with malignant brain tumours in south east Scotland. Health Bull (Edinb) 1996 0.84
38 Recording neurological impairment in clinical trials of glioma. J Neurooncol 1994 0.83
39 Heme arginate (Normosang) in the treatment of attacks of acute hepatic porphyrias. Mater Med Pol 1992 0.83
40 Family study in congenital erythropoietic porphyria. S Afr Med J 1971 0.83
41 The effect on human neuroblastoma spheroids of fractionated radiation regimes calculated to be equivalent for damage to late responding normal tissues. Eur J Cancer Clin Oncol 1987 0.82
42 Familial glioma: a report of glioblastoma in identical twins and oligo-astrocytoma in siblings. Br J Neurosurg 1989 0.82
43 The prognostic influence of bcl-2 in malignant glioma. Br J Cancer 2002 0.82
44 Apoptosis in human primary brain tumours: actions of arachidonic acid. Prostaglandins Leukot Essent Fatty Acids 1998 0.82
45 Neurological and cognitive impairment in long-term survivors of small cell lung cancer. Eur J Cancer 1994 0.81
46 Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non small-cell lung cancer after a response to induction chemotherapy. EORTC 08941. Clin Lung Cancer 2000 0.81
47 Small cell lung cancer. Lung Cancer 1997 0.81
48 Immunoelectron microscopy of Rosenthal fibers. Acta Neuropathol 1991 0.80
49 Immunohistochemical and ultrastructural studies of stromal cells in hemangioblastoma. Folia Neuropathol 1995 0.79
50 Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 1994 0.79
51 Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962-1990. Clin Oncol (R Coll Radiol) 1994 0.79
52 Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II study. Ann Oncol 1990 0.79
53 Increasing incidence of CNS primary lymphoma in south-east Scotland. Lancet 1991 0.79
54 Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial. J Neurol Neurosurg Psychiatry 1998 0.79
55 Radiobiological considerations in the treatment of neuroblastoma by total body irradiation. Radiother Oncol 1986 0.79
56 Retinoic acid- and staurosporine-induced bidirectional differentiation of human neuroblastoma cell lines. Exp Cell Res 1992 0.78
57 Tumor spheroid model for the biologically targeted radiotherapy of neuroblastoma micrometastases. Cancer Res 1990 0.78
58 [Quality of life of severely injured patients 1 year after trauma. A matched-pair study compared with a healthy control group]. Unfallchirurg 2001 0.78
59 The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clin Endocrinol (Oxf) 2002 0.78
60 Management of patients aged over 60 years with supratentorial glioma: lessons from an audit. Surg Neurol 1991 0.78
61 Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy. Acta Neuropathol 1993 0.77
62 Trends in classification, referral and treatment and the effect on outcome of patients with glioma: a 20 year cohort. J Neurooncol 2011 0.77
63 Gemcitabine and radiation therapy for non-small cell lung cancer. Semin Oncol 1998 0.77
64 Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome. Br J Neurosurg 2002 0.77
65 New missense mutation in the human ferrochelatase gene in a family with erythropoietic protoporphyria: functional studies and correlation of genotype and phenotype. Clin Chem 2001 0.77
66 [Acetylcholinesterase-positive innervation of the thymus in old rats after ovariectomy]. Bratisl Lek Listy 1996 0.76
67 Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria. Ann Clin Res 1986 0.76
68 Short duration combination chemotherapy in the treatment of small cell lung cancer. Thorax 1986 0.76
69 Strategy needed for adolescent patients with cancer. BMJ 1995 0.76
70 Long-term survival in adult hemispheric glioma: prognostic factors and quality of outcome. Clin Oncol (R Coll Radiol) 1990 0.76
71 The treatment of brain metastases from lung cancer. Lung Cancer 1998 0.76
72 [Evaluation of the diagnostic usefulness of determining porphobilinogen deaminase activity in the erythrocytes in patients with acute intermittent porphyria and in carriers of the gene of this type of porphyria]. Przegl Lek 1986 0.76
73 Radiotherapy for malignant glioma. BMJ 1996 0.75
74 Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status? Medical Research Council Lung Cancer Working Party. Br J Cancer 1994 0.75
75 Increased protoporphyrin in erythrocytes in a child with acute intermittent porphyria. Arch Dis Child 1977 0.75
76 The treatment of primary malignant brain tumours. J Neurol Neurosurg Psychiatry 1991 0.75
77 Cranial irradiation in small cell lung cancer. Br J Cancer 1991 0.75
78 Lymphatics and bone marrow. Folia Morphol (Praha) 1965 0.75
79 Single photon emission computed tomography in long-term survivors of adult brain tumours. J Neurol Neurosurg Psychiatry 1994 0.75
80 Regarding "Longer survival and higher doses of thoracic radiotherapy in patients with limited non-small lung cancer". Int J Radiat Oncol Biol Phys 1994 0.75
81 [Diagnosis of acute intermittent porphyria in 35 persons. An analysis]. Pol Tyg Lek 1977 0.75
82 [Acute hepatic porphyrias. Work based on data collected at the Institute of Hematology 1962-1980]. Pol Tyg Lek 1983 0.75
83 [Acute attack of porphyria and its results]. Pol Arch Med Wewn 1986 0.75
84 Fourth ventricle ependymoma in father and son. Br J Neurosurg 2008 0.75
85 [Porphyria variegata in a 9-year-old girl]. Pediatr Pol 1980 0.75
86 [Prevention of porphyria]. Pol Tyg Lek 1987 0.75
87 CLINICAL OBSERVATIONS ON AN EPIDEMIC OF ACUTE POLIOMYELITIS IN CORNWALL. Br Med J 1911 0.75
88 Non-small cell lung cancer: are we out of step? Clin Oncol (R Coll Radiol) 1995 0.75
89 Kinetics of reactive oxygen intermediate formation and apoptosis in human glioma and glioma C6 cell line: effects of radiation and n-6 essential fatty acids. Biochem Soc Trans 1998 0.75
90 Combined modality therapy in small cell lung cancer. Lung Cancer 1994 0.75
91 [New type of dextran and its clinical use; half-life and urinary excretion]. Pol Tyg Lek 1980 0.75
92 [Tissue damage caused by parenteral injection of solutions of varying osmolality]. Pol Tyg Lek 1972 0.75
93 [Gelatin solutions transfusion in patients in the course of surgery]. Pol Tyg Lek 1978 0.75
94 [Evaluation of porphyrogenic action of selected drugs]. Pol Tyg Lek 1979 0.75
95 Potential of electric discharge plasma methods in abatement of volatile organic compounds originating from the food industry. J Environ Manage 2012 0.75
96 Common regional lymph nodes of the lungs and heart in the hedgehog. Folia Morphol (Praha) 1983 0.75
97 [Biological action of low-molecular weight Dextran, Polfa: its effect on erythrocyte sedimentation rate]. Pol Tyg Lek 1971 0.75
98 International survey of radiotherapy practice for radical treatment of non-small cell lung cancer. Lung Cancer 1994 0.75
99 Nine novel mutations in the hydroxymethylbilane synthase gene of Polish patients with acute intermittent porphyria. Clin Genet 2006 0.75
100 Proceedings: Note on lymph drainage of the heart in the dog. Folia Morphol (Praha) 1974 0.75
101 TWO CASES TREATED with INJECTIONS of ANTISTREPTOCOCCUS SERUM. Br Med J 1898 0.75
102 Computed tomography in the assessment of malignant mesothelioma of the pleura. Clin Radiol 1982 0.75
103 Managed clinical network in practice--is it working? Clin Oncol (R Coll Radiol) 2003 0.75
104 Acute intermittent porphyria in Poland. S Afr Med J 1971 0.75
105 [Acute intermittent porphyria in differential diagnosis of acute abdominal diseases]. Pol Tyg Lek 1974 0.75
106 [Blood concentration of dextran during treatment of thromboembolic complications]. Pol Tyg Lek 1971 0.75
107 [Diagnosis of acute intermittent porphyria on the basis of uroporphyrinogen I synthase activity in the erythrocytes; comparison of 2 methods]. Pol Tyg Lek 1979 0.75
108 [Acute hepatic porphyrias. II. Comparison of the intensity of histological and ultrastructural changes with the degree of liver function disorders based on the breath test with C-14-aminopyrine and serum bile acid level]. Pol Arch Med Wewn 1984 0.75
109 [Total protein content and protein fraction pattern in serum of patients after thyroidectomy]. Pol Tyg Lek 1972 0.75
110 [Organization and results of studies on acute hepatic porphyrias in Poland]. Gematol Transfuziol 1993 0.75
111 [Uniform programme in caring for patients with acute hepatic porphyria]. Pol Arch Med Wewn 2001 0.75
112 [Porphyria--a pharmacogenetic disease]. Wiad Lek 1986 0.75
113 [Effect of dextran-40 infusion on the behavior of serum proteins]. Pol Tyg Lek 1971 0.75
114 [Total and ionized serum calcium levels following surgery on the thyroid gland]. Pol Tyg Lek 1975 0.75
115 [Effect of hematin injection on delta-aminolevulinic acid synthetase activity in the rat liver]. Acta Haematol Pol 1985 0.75
116 Acute toxicity of alternating schedule of chemotherapy and irradiation in limited small-cell lung cancer in a pilot study (08877) of the EORTC Lung Cancer Cooperative Group. Ann Oncol 1995 0.75
117 Urinary excretion of 5-aminolevulinate and porphobilinogen in diabetes. Diabetologia 1971 0.75
118 [Localization of NADPH-d positive cells in the thymus of pheasants and mice]. Bratisl Lek Listy 1998 0.75
119 Prophylactic cranial irradiation in small cell lung cancer (SCLC) makes a comeback. Clin Oncol (R Coll Radiol) 1997 0.75
120 Topography of regional lymph nodes of lung in the rhesus monkey (Macaca mulatta). Folia Morphol (Praha) 1967 0.75
121 Clinical Observations on an Epidemic of Acute Poliomyelitis in Cornwall. Proc R Soc Med 1912 0.75
122 [Group structures of erythrocytes. Structure of glycolipids with H and B activity and of the main ganglioside of erythrocytes containing glucosamine and sialic acid]. Acta Haematol Pol 1973 0.75
123 [Acute hepatic porphyria. II]. Acta Haematol Pol 1988 0.75
124 [Preliminary clinical evaluation of the preparation Fluigel-Polfa]. Pol Tyg Lek 1979 0.75
125 A NOTE ON THE EPIDEMIOLOGY OF INFLUENZA AMONG WORKERS: In Gas Works, in a Cordite Factory, and in a Tin Mine. Br Med J 1919 0.75
126 [Effect of Gelafusal infusion on renal function]. Pol Tyg Lek 1978 0.75
127 cis-Platinum and vindesine in combination in the treatment of non-small cell lung cancer. Eur J Cancer Clin Oncol 1985 0.75
128 Hormonal abnormalities in survivors of primary brain tumours. Radiother Oncol 1993 0.75
129 Determination of serum proteins in the presence of dextran by means of the biuret reaction. Infusionsther Klin Ernahr 1977 0.75
130 [Current views on the etiology and pathogenesis of acute intermittent porphyria]. Neurol Neurochir Psychiatr Pol 1966 0.75
131 Biological effects of low-molecular weight dextran "Polfa". The effect on the erythrocyte sedimentation rate. Pol Med J 1971 0.75
132 Evaluation of rheological properties of dextran-40 Polfa. Pol Med Sci Hist Bull 1969 0.75
133 The management of non-small-cell lung cancer: a case history. Ann Oncol 1999 0.75
134 [Intraoperative blood loss and its significance in surgery]. Pol Tyg Lek 1968 0.75
135 Radiotherapy with/without cisplatin following chemotherapy in limited small-cell lung cancer. J Clin Oncol 1998 0.75
136 Studies of plasma volume after infusion of dextran-70 Polfa. Pol Med Sci Hist Bull 1969 0.75
137 Radiobiological rationale for hyperfractionation in the radiotherapy of neuroblastoma. Int J Radiat Oncol Biol Phys 1987 0.75
138 [Gangliosides in human erythrocytes]. Acta Haematol Pol 1974 0.75
139 [Effect of the pH of solutions used topically on the bacterial flora of burn wounds]. Pol Tyg Lek 1972 0.75
140 Acute intermittent porphyria with emergency surgical manifestations. Bull Soc Int Chir 1975 0.75
141 [Complications after dextran infusions in the years 1973-1977]. Pol Tyg Lek 1980 0.75
142 [Quantification of pericentral NADPH-diaphorase neurons in the spinal cord of rabbits]. Bratisl Lek Listy 1998 0.75
143 Common regional lymph nodes for the human lungs and heart. Folia Morphol (Praha) 1982 0.75
144 [Attempted evaluation of the rheological properties of dextran 40 "Polfa"]. Pol Tyg Lek 1969 0.75
145 [Porphyria variegata in Poland. Diagnosis and differentiation]. Pol Arch Med Wewn 1980 0.75
146 [Hemodynamic properties of low molecular dextran in experimental clinical conditions]. Pol Tyg Lek 1967 0.75
147 Ketamine in acute intermittent porphyria--dangerous or safe? Anesthesiology 1978 0.75
148 The effect of dextran-40 infusion on the serum proteins. Pol Med J 1971 0.75
149 [A decrease in plasma sodium ion during the course of an acute attack of porphyria]. Pol Tyg Lek 1991 0.75
150 [Normal activity of uroporphyrinogen I synthase during an attack of acute intermittent porphyria]. Pol Tyg Lek 1980 0.75
151 Optimal scheduling of total body irradiation in the treatment of Ewing's sarcoma. Int J Radiat Oncol Biol Phys 1985 0.75
152 Infradiaphragmatic presentation of Hodgkin's disease. Clin Radiol 1981 0.75
153 Acute hepatic porphyria in Poland. Lancet 1982 0.75
154 The topography and tributary areas of the bronchopulmonary lymph nodes of left lungs. Folia Morphol (Praha) 1972 0.75
155 [Neurologic disorders in acute intermittent porphyria]. Neurol Neurochir Pol 1978 0.75
156 [Erythropoietic protoporphyria]. Przegl Dermatol 1988 0.75
157 [New oral antibiotic-cephalexin]. Cas Lek Cesk 1971 0.75
158 [Intraoperative hemodilution with gelatin solutions]. Pol Przegl Chir 1978 0.75
159 The implications of in-vitro radiation-survival curves for the optimal scheduling of total-body irradiation with bone marrow rescue in the treatment of leukaemia. Br J Radiol 1987 0.75
160 The function and morphology of the liver in porphyria cutanea tarda. Ann Clin Res 1984 0.75
161 [[35 Years of effort to improve the diagnosis of porphyria]. Przegl Lek 1999 0.75
162 Hemodynamic properties of low-molecular weight dextran under experimental clinical conditions. Pol Med J 1968 0.75
163 [Diagnostic difficulties in disorders of porphyrin metabolism]. Pol Tyg Lek 1981 0.75
164 Network analysis of arachidonic acid pathophysiology in human phagocytes and primary brain tumors. Ann N Y Acad Sci 1997 0.75
165 [Change in the volume of circulating blood following transfusions of blood, plasma and certain infusion fluids]. Probl Gematol Pereliv Krovi 1973 0.75
166 [Analysis of factors inducing attacks of acute intermittent porphyria in the records of the Institute of Hematology in the years 1962-1976]. Pol Tyg Lek 1977 0.75
167 [Studies on the behavior of plasma volume after transfusion of Dextran-70 "Polfa"]. Pol Tyg Lek 1969 0.75
168 Acute hepatic porphyrias. Detection, prophylaxis and treatment. Mater Med Pol 1997 0.75
169 Management of small cell cancer: intensive chemotherapy. Recent Results Cancer Res 1984 0.75
170 [Hereditary coproporphyria]. Pol Arch Med Wewn 1981 0.75
171 THE SCOPE OF CERTAIN GASEOUS DISINFECTANTS IN THE PROPHYLAXIS OF INFLUENZA. Br Med J 1919 0.75
172 [Acute porphyria diagnosed 9 years after death according to family examinations (confirmed neuropathologically)]. Neurol Neurochir Pol 1967 0.75
173 [Acute hepatic porphyrias. 1. The breath test with C-14-aminopyrine, serum bile acid levels and routine tests in the evaluation of liver function]. Pol Arch Med Wewn 1984 0.75
174 [Effect of osmolality of solutions used locally on the bacterial flora of burn wounds]. Pol Tyg Lek 1975 0.75
175 [Genetic studies of families of patients with porphyria. Determination of uroporphyrinogen I synthase in the erythrocytes]. Pol Arch Med Wewn 1979 0.75